Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO): A multicenter, randomized phase 3 trial.
暂无分享,去创建一个
J. Trojan | G. Folprecht | M. Schuler | W. Schmiegel | R. Hofheinz | W. Fischbach | S. Al-Batran | S. Probst | T. Goetze | P. Thuss-Patience | C. Pauligk | N. Homann | H. Kopp | M. Koenigsmann | E. Jaeger | K. Luley | J. Meiler | G. Haag | N. Prasnikar | H. Schmalenberg